Its portability and ease of use have made it a preferred choice for those seeking asthma relief and COPD treatment. The upgraded device delivers precise atomization, ensuring that medication ...

The Nose Knows: Nasal Swab Detects Asthma Type in Kids Jan. 2, 2025 — A new, non-invasive nasal swab test for kids that diagnoses specific asthma subtype, or endotype, could help clinicians ...

Ultrafine Mist: Our rechargeable nebulizer uses advanced ultrasonic mesh technology to transform liquids into fine mist particles. Two Adjustable Modes: Featuring two modes, the Strong Mode ...

It can be difficult to tell asthma and COPD apart because both may include coughing, wheezing, and shortness of breath. Asthma is a risk factor for COPD and your chances of having both increase as ...

The NE-U22V MicroAir®, the world’s smallest nebulizer utilizing Vibrating Mesh Technology (V.M.T.), efficiently delivers solution medications for patients suffering from asthma, COPD or other ...

In today's fast-paced world, many individuals struggle with respiratory issues, whether due to chronic conditions like asthma ...

The powerful Inspiration Elite is the newest and lightest compressor nebulizer system in the Respironics family is here. It's durable, easy to use and easy to maintain. But best of all ...

Nebulizers are small devices that help take various drugs used to manage COPD. They use a motor to convert these drugs from liquid to mist. This helps deliver a continuous medication mist that you ...

creating a liquid film. This film breaks apart due to surface tension, forming aerosol particles. Baffles incorporated into the interior design of the nebulizer produce smaller particles and force ...

A nebulizer is a medical device that converts liquid medication into a fine mist, which someone inhales. The nebulizer has a face mask or a mouthpiece and is powered using a battery or electrical ...

Cipla share price today: The pharma major reported a 49% increase in net profit, reaching Rs 1,571 crore (Image: Reuters) Motilal Oswal has maintained a Neutral rating on Cipla, with a target ...